The estimated Net Worth of Sudhir K Pahwa is at least $4.59 Million dollars as of 25 May 2018. Sudhir Pahwa owns over 1,611 units of Steris Plc stock worth over $3,384,725 and over the last 9 years Sudhir sold STE stock worth over $1,209,083.
Sudhir has made over 10 trades of the Steris Plc stock since 2016, according to the Form 4 filled with the SEC. Most recently Sudhir sold 1,611 units of STE stock worth $167,882 on 25 May 2018.
The largest trade Sudhir's ever made was selling 3,000 units of Steris Plc stock on 1 June 2017 worth over $237,210. On average, Sudhir trades about 759 units every 35 days since 2015. As of 25 May 2018 Sudhir still owns at least 13,983 units of Steris Plc stock.
You can see the complete history of Sudhir Pahwa stock trades at the bottom of the page.
Sudhir's mailing address filed with the SEC is Stephensons Way, Derby DE21 6LY, UK.
Over the last 9 years, insiders at Steris Plc have traded over $157,726,045 worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves, Walter M Jr Rosebrough, and John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of $3,374,074. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth $113,369.
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
Steris Plc executives and other stock owners filed with the SEC include: